1. Xu, Shaohai, Lai, Soak-Kuan, Sim, Donald Yuhui, Li, Hoi Yeung, Roca, Xavier. . SRRM2 organizes splicing condensates to regulate alternative splicing. In Nucleic acids research, 50, 8599-8614. doi:10.1093/nar/gkac669. https://pubmed.ncbi.nlm.nih.gov/35929045/
2. Cuinat, Silvestre, Nizon, Mathilde, Isidor, Bertrand, Bezieau, Stéphane, Cogné, Benjamin. 2022. Loss-of-function variants in SRRM2 cause a neurodevelopmental disorder. In Genetics in medicine : official journal of the American College of Medical Genetics, 24, 1774-1780. doi:10.1016/j.gim.2022.04.011. https://pubmed.ncbi.nlm.nih.gov/35567594/
3. Ilik, İbrahim Avşar, Malszycki, Michal, Lübke, Anna Katharina, Meierhofer, David, Aktaş, Tuğçe. 2020. SON and SRRM2 are essential for nuclear speckle formation. In eLife, 9, . doi:10.7554/eLife.60579. https://pubmed.ncbi.nlm.nih.gov/33095160/
4. Zhang, Tao, Xu, Lei, Zhu, Hongdan, Jin, Xin, Xia, Guiyu. 2023. Familial and genetic association with neurodevelopmental disorders caused by a heterozygous variant in the SRRM2 gene. In Frontiers in endocrinology, 14, 1240168. doi:10.3389/fendo.2023.1240168. https://pubmed.ncbi.nlm.nih.gov/37621647/
5. Tomsic, Jerneja, He, Huiling, Akagi, Keiko, Blencowe, Benjamin J, de la Chapelle, Albert. 2015. A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition. In Scientific reports, 5, 10566. doi:10.1038/srep10566. https://pubmed.ncbi.nlm.nih.gov/26135620/
6. Shehadeh, Lina A, Yu, Kristine, Wang, Liyong, Vance, Jeffery, Papapetropoulos, Spyridon. 2010. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. In PloS one, 5, e9104. doi:10.1371/journal.pone.0009104. https://pubmed.ncbi.nlm.nih.gov/20161708/
智鼠故事 
